首頁 > 市場調查報告書 > 醫療設備

激光

市場調查報告書

商品編碼

1495999

治療雷射全球市場 - 2024 年至 2029 年預測

Global Therapeutic Laser Market - Forecasts from 2024 to 2029

出版日期: 2024年04月17日 | 出版商:

Knowledge Sourcing Intelligence | 英文 134 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

治療雷射市場預計將從 2022 年的 1,258.05 億美元增至 2029 年的 2,370.22 億美元，預測期內複合年成長率為 9.47%。

雷射治療系統是一種無藥物、非侵入性的治療方法，可以緩解慢性和急性疼痛，同時改善血液循環。這些設備採用雷射脈衝穿經皮膚，不會造成發熱、傷害或其他負面影響。雷射治療系統可加速創傷治療並減少軟組織發炎和不適。這種雷射治療被定位為標準藥物和手術治療的替代方案（如果不是輔助的話）。這些雷射系統透過解決疾病的根本原因提供長期的治療效果。

治療雷射，也稱為低強度雷射或冷雷射，是醫療設備。它用於多種醫療應用，包括疼痛管理、創傷治療和組織修復。該市場包括不同類型的治療雷射器，例如二極體雷射、染料雷射和 CO2 雷射。治療性雷射廣泛應用於緩解疼痛、創傷治療、皮膚科和牙科。該市場的主要市場參與企業包括成熟的醫療設備公司和新興市場參與企業。

FDA 和 EMA 等衛生當局的監管核准對於進入市場至關重要。阻礙因素包括提供者和患者對雷射治療的好處和報銷問題的認知有限。未來的趨勢包括與其他技術、家用設備的整合以及正在進行的研究和臨床試驗。由於意識的提高、技術的進步以及對非侵入性治療方案的需求不斷成長，治療雷射市場預計將在全球範圍內擴張。

市場促進因素：

預計癌症發生率的增加將推動全球對治療雷射的需求。

由於全球癌症發病率上升、手術數量增加以及自我護理和自我管理意識的增強，對治療雷射的需求正在增加。此外，可支配收入的增加、醫療保健支出的增加和住院時間的縮短將在預計的十年及更長時間內推動全球治療雷射市場的發展。

此外，多家公司已主動推出創新新產品，推動了預測期內的市場成長。例如，加拿大的Theralase Technology公司在抗癌治療（ACT）和醫療雷射技術（MLT）領域均生產專利雷射技術，並將於2021年宣布推出突破性的新型疼痛和癌症解決方案。該公司還透露，其領先的 PDC 可以消滅多種病毒，包括 H1N1 流感和茲卡。

北美地區的全球市場佔有率預計將迅速增加。

北美傳統上一直是治療雷射的主要市場，但全球市場佔有率預計將迅速增加。這是由於該地區幾個國家對整容手術的需求不斷成長。使用雷射治療進行靜脈、表面置換和除毛的主要美容療程在該地區顯著增加。例如，根據美國整形外科醫師協會的年度報告，2020年有168,682例雷射靜脈治療、997,245例雷射換膚表面置換、757,808例雷射除毛治療。因此，這些廣泛的醫療應用和這些手術的廣泛採用正在推動該地區治療雷射市場的需求。

此外，對這些雷射的需求不斷成長也是由於該地區專利數量的增加。例如，2021 年 7 月，領先的醫療解決方案公司 Aspen Laser LLC 獲得了美國專利商標局 (USPTO) 的新專利。據報道，該專利涵蓋了該公司製造並在獸醫和醫療市場銷售的某些雷射設備。

此外，該地區的主要企業正致力於實施合併、合作協議和收購等策略性舉措，以加強其市場地位。例如，2021年9月，波士頓科學公司從BPEA（霸菱亞洲私募股權公司）的關聯公司完成了對能源醫療解決方案公司Lumenis LTD的全球外科業務的收購。 Lumenis 的外科業務包括用於耳鼻喉科和泌尿系統手術的光纖、先進雷射系統和配件。此類新興市場的開拓預計將進一步推動市場成長。

市場的主要發展：

2023 年 6 月 - 牙科雷射領域的全球領導者 BioLASE 與美國頂級非麻醉寵物牙科提供者 Pet Dental Services (PDS) 合作，整合 BIOLASE 的二極體雷射技術。 PDS旨在獲得全國獸醫的信任和信心，並透過獸醫醫院提供服務。 PDS 在超過 300 名獸醫組成的網路中享有盛譽。 BioLASE的二極體雷射技術不僅可以治療牙周病，還可以幫助您的寵物過上健康的生活。 BioLASE 的專有雷射產品包含約 266 項取得專利的技術和 25 項正在申請專利的技術，並記錄了卓越的生物和臨床性能，可減少疼痛並加快恢復速度。
2023 年 4 月 - Lumibird Medical 推出了 Ellex(R) 的兩款全新下一代 Nd:YAG/SLT 雷射、Tango(TM) Neo 和 Ultra Q(TM) Reflex Neo。 Tango Reflex(TM) Neo 是一種完全整合的Q 開關Nd:YAG，用於眼前段YAG 和青光眼，採用第二代Reflex(TM) 技術和真正的同軸照明(TCI(TM))，它是一種雷射。它還具有 Imprint(TM)、動態抬頭顯示器、用於能量設定的操縱桿控制以及用於 PROcap(TM) 的高達 2mm YAG 後偏移 - 高級屈光結果囊切開術。 Tango(TM) Neo 是一個改進的通用使用者介面，具有現代的外觀和感覺。
2023 年 4 月 - Topcon Corporation 將與 Espansione Group 合作，在東南亞地區銷售該公司的光學技術。透過此次合作，拓普康將推出光調製(R) 低強度光療法(LM(R) LLLT)、光生物調製技術和最佳功率能量(R) 強脈衝光(OPE(R) IPL) 等創新療法。這項戰略合作關係將使 Espansione 能夠突破亞太地區和東南亞眼科護理的界限。拓普康的服務範圍已擴大到包括從預測到有效乾眼治療和治療後追蹤的全面解決方案。

A therapeutic laser system is a drug-free, non-invasive therapy approach that relieves chronic and acute pain while also improving blood circulation. These devices employ laser pulses that penetrate through the skin without creating warmth, injury, or other negative effects. The therapeutic laser system speeds up wound healing and lowers soft tissue inflammation and discomfort. This laser therapy is viewed as an alternative, if not a supplement, to standard medication and surgical treatment. These laser systems include a long-term therapeutic effect by addressing the fundamental causes of illness disorders.

Therapeutic lasers, also known as low-level lasers or cold lasers, are medical devices that use low-level light to stimulate cellular function and promote healing. They are used in various medical and healthcare applications for pain management, wound healing, and tissue repair. The market includes different types of therapeutic lasers, such as diode lasers, dye lasers, and CO2 lasers. Therapeutic lasers are widely used for pain relief, wound healing, dermatology, and dentistry. Key players in the market include established medical device companies and emerging players.

Regulatory approvals from health authorities like the FDA and EMA are essential for market entry. Restraints include limited awareness among healthcare providers and patients about therapeutic lasers' benefits and reimbursement issues. Future trends include integration with other technologies, home-use devices, and ongoing research and clinical trials. The global therapeutic laser market is expected to expand globally due to increased awareness, technological advancements, and growing demand for non-invasive therapeutic options.

Market Drivers:

Increased cancer incidences are anticipated to propel the demand for therapeutic lasers globally.

The need for a therapeutic laser is increasing due to rising cancer occurrences globally, an increase in the number of operations, and increased awareness of self-care and self-management. Furthermore, increased disposable income, rising healthcare spending, and shorter hospital stays would drive the worldwide therapeutic laser market in the projected decade and beyond.

Moreover, several companies have taken the initiative to launch new innovative products that have propelled the market to grow during the projected period. For instance, Theralase Technology, a Canadian producer of patent laser technologies in both the Anti-Cancer Therapy (ACT) and Medical Laser Technology (MLT) sectors, intends to introduce new, breakthrough pain and cancer solutions in 2021. They've also shown that their primary PDC can eliminate several viruses, including H1N1 flu and Zika.

North America region is expected to witness a surge in its global market share.

North America has been a major market for therapeutic lasers until now and is expected to surge in its global market share. This can be attributed to the growing prevalence of demand for cosmetic surgeries across several countries in this region. Primary cosmetic treatments for veins, skin resurfacing, and hair removal using laser therapy have increased significantly in the region. For instance, according to the American Society of Plastic Surgeons annual report, it was reported that 168,682 laser treatments for veins, 997,245 laser skin resurfacing, and 757,808 laser removal procedures were performed in 2020. Thus, these extensive medical applications and the wide adoption of these procedures have propelled the demand for the therapeutic lasers market in the region.

Further, the growing demand for these lasers can also be attributed to an increase in the provision of patents in the region. For instance, in July 2021, Aspen Laser LLC, which is a major medical solutions company, was awarded a new patent by the USPTO (U.S. Patent and Trademark Office). The patent was reported to cover particular laser devices that would be manufactured by the company and sold in the veterinary and medical markets.

Furthermore, major companies in the region have been focused on the implementation of strategic initiatives, such as mergers, collaborative agreements, and acquisitions, for the consolidation of their position in the market. For instance, in September 2021, Boston Scientific completed the acquisition of the worldwide surgical business of Lumenis LTD, an energy-based medical solutions company, from an affiliate of BPEA (Baring Private Equity Asia). The surgical business of Lumenis comprised of fibers, premier laser systems, and accessories that are deployed in the otolaryngology and urology procedures. Thus, developments like these are further expected to propel the market growth.

Market Key Developments:

June 2023- BioLASE, a global leader in dental lasers, partnered with Pet Dental Services (PDS), the top non-anesthetic pet dental provider in the country, to integrate BIOLASE's diode laser technology. PDS aims to gain the trust and confidence of veterinarians across the country, providing service through veterinary hospitals. PDS has an excellent reputation among a network of over 300 veterinarians. BioLASE's diode laser technology not only treats periodontal disease but also helps pets live healthier lives BioLASE's proprietary laser products incorporate approximately 266 patented and 25 patent-pending technologies, providing biologically and clinically superior performance with less pain and faster recovery times.
April 2023- Lumibird Medical launched two new next-generation Nd:YAG/SLT lasers, the Tango(TM) Neo and Ultra Q(TM) Reflex Neo, by Ellex(R). The Tango Reflex(TM) Neo is a fully integrated Q-switched Nd:YAG laser for anterior-segment YAG and glaucoma indications, featuring second-generation Reflex(TM) technology with True Coaxial Illumination (TCI(TM)). It also includes Imprint(TM), a dynamic heads-up display, joystick control of energy settings, and up to 2 mm YAG posterior offset for PROcap(TM) - Premium Refractive Outcome Capsulotomies. The Tango(TM) Neo has an improved general user interface with a modern look and feel. The lasers are CE-marked and USA FDA 510K approved.
April 2023- Topcon Corporation partnered with Espansione Group to distribute their light-based technologies in the Southeast Asian region. The partnership allows Topcon to access innovative treatment products like Light Modulation(R) Low-level Light Therapy (LM(R) LLLT), photobiomodulation technology, and Optimal Power Energy(R) Intense Pulsed Light (OPE(R) IPL). This strategic alliance enables Espansione to push the boundaries of ophthalmology in APAC and SEA. Topcon's service spectrum expand, offering comprehensive solutions from pre-diagnosis to effective dry eye treatment and post-treatment follow-ups.

Market Segmentation:

By Therapy

Carbon Dioxide Laser
YAG (yttrium aluminum garnet) Laser
Pulsed Dye Laser
Argon Laser
Low-level laser therapy (LLLT)

By Application

LASIK or Laser Eye Surgery
Teeth Whitening
Cosmetic Scar, Tattoo or Wrinkle Removal
Tumor Removal
Others

By Geography

North America
USA
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
Germany
France
United Kingdom
Spain
Others
Middle East and Africa
Saudi Arabia
UAE
Others
Asia Pacific
China
Japan
South Korea
India
Thailand
Others

1. INTRODUCTION

1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base and Forecast Years Timeline
1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY

2.1. Research Design
2.2. Research Processes

3. EXECUTIVE SUMMARY

3.1. Key Findings

4. MARKET DYNAMICS

4.1. Market Drivers
4.2. Market Restraints
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers
- 4.3.2. Bargaining Power of Buyers
- 4.3.3. Threat of New Entrants
- 4.3.4. Threat of Substitutes
- 4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
4.5. Analyst View

5. GLOBAL THERAPEUTIC LASER MARKET BY THERAPY

5.1. Introduction
5.2. Carbon Dioxide Laser
- 5.2.1. Market Opportunities and Trends
- 5.2.2. Growth Prospects
- 5.2.3. Geographic Lucrativeness
5.3. YAG (yttrium aluminum garnet) Laser
- 5.3.1. Market Opportunities and Trends
- 5.3.2. Growth Prospects
- 5.3.3. Geographic Lucrativeness
5.4. Pulsed Dye Laser
- 5.4.1. Market Opportunities and Trends
- 5.4.2. Growth Prospects
- 5.4.3. Geographic Lucrativeness
5.5. Argon Laser
- 5.5.1. Market Opportunities and Trends
- 5.5.2. Growth Prospects
- 5.5.3. Geographic Lucrativeness
5.6. Low-level laser therapy (LLLT)
- 5.6.1. Market Opportunities and Trends
- 5.6.2. Growth Prospects
- 5.6.3. Geographic Lucrativeness

6. GLOBAL THERAPEUTIC LASER MARKET BY APPLICATION

6.1. Introduction
6.2. LASIK or Laser Eye Surgery
- 6.2.1. Market Opportunities and Trends
- 6.2.2. Growth Prospects
- 6.2.3. Geographic Lucrativeness
6.3. Teeth Whitening
- 6.3.1. Market Opportunities and Trends
- 6.3.2. Growth Prospects
- 6.3.3. Geographic Lucrativeness
6.4. Cosmetic Scar, Tattoo or Wrinkle Removal
- 6.4.1. Market Opportunities and Trends
- 6.4.2. Growth Prospects
- 6.4.3. Geographic Lucrativeness
6.5. Tumor Removal
- 6.5.1. Market Opportunities and Trends
- 6.5.2. Growth Prospects
- 6.5.3. Geographic Lucrativeness
6.6. Others
- 6.6.1. Market Opportunities and Trends
- 6.6.2. Growth Prospects
- 6.6.3. Geographic Lucrativeness

7. GLOBAL THERAPEUTIC LASER MARKET BY GEOGRAPHY

7.1. Introduction
7.2. North America
- 7.2.1. By Therapy
- 7.2.2. By Application
- 7.2.3. By Country
  - 7.2.3.1. USA
    - 7.2.3.1.1. Market Opportunities and Trends
    - 7.2.3.1.2. Growth Prospects
  - 7.2.3.2. Canada
    - 7.2.3.2.1. Market Opportunities and Trends
    - 7.2.3.2.2. Growth Prospects
  - 7.2.3.3. Mexico
    - 7.2.3.3.1. Market Opportunities and Trends
    - 7.2.3.3.2. Growth Prospects
7.3. South America
- 7.3.1. By Therapy
- 7.3.2. By Application
- 7.3.3. By Country
  - 7.3.3.1. Brazil
    - 7.3.3.1.1. Market Opportunities and Trends
    - 7.3.3.1.2. Growth Prospects
  - 7.3.3.2. Argentina
    - 7.3.3.2.1. Market Opportunities and Trends
    - 7.3.3.2.2. Growth Prospects
  - 7.3.3.3. Others
    - 7.3.3.3.1. Market Opportunities and Trends
    - 7.3.3.3.2. Growth Prospects
7.4. Europe
- 7.4.1. By Therapy
- 7.4.2. By Application
- 7.4.3. By Country
  - 7.4.3.1. Germany
    - 7.4.3.1.1. Market Opportunities and Trends
    - 7.4.3.1.2. Growth Prospects
  - 7.4.3.2. France
    - 7.4.3.2.1. Market Opportunities and Trends
    - 7.4.3.2.2. Growth Prospects
  - 7.4.3.3. United Kingdom
    - 7.4.3.3.1. Market Opportunities and Trends
    - 7.4.3.3.2. Growth Prospects
  - 7.4.3.4. Spain
    - 7.4.3.4.1. Market Opportunities and Trends
    - 7.4.3.4.2. Growth Prospects
  - 7.4.3.5. Others
    - 7.4.3.5.1. Market Opportunities and Trends
    - 7.4.3.5.2. Growth Prospects
7.5. Middle East and Africa
- 7.5.1. By Therapy
- 7.5.2. By Application
- 7.5.3. By Country
  - 7.5.3.1. Saudi Arabia
    - 7.5.3.1.1. Market Opportunities and Trends
    - 7.5.3.1.2. Growth Prospects
  - 7.5.3.2. UAE
    - 7.5.3.2.1. Market Opportunities and Trends
    - 7.5.3.2.2. Growth Prospects
  - 7.5.3.3. Others
    - 7.5.3.3.1. Market Opportunities and Trends
    - 7.5.3.3.2. Growth Prospects
7.6. Asia Pacific
- 7.6.1. By Therapy
- 7.6.2. By Application
- 7.6.3. By Country
  - 7.6.3.1. China
    - 7.6.3.1.1. Market Opportunities and Trends
    - 7.6.3.1.2. Growth Prospects
  - 7.6.3.2. Japan
    - 7.6.3.2.1. Market Opportunities and Trends
    - 7.6.3.2.2. Growth Prospects
  - 7.6.3.3. South Korea
    - 7.6.3.3.1. Market Opportunities and Trends
    - 7.6.3.3.2. Growth Prospects
  - 7.6.3.4. India
    - 7.6.3.4.1. Market Opportunities and Trends
    - 7.6.3.4.2. Growth Prospects
  - 7.6.3.5. Thailand
    - 7.6.3.5.1. Market Opportunities and Trends
    - 7.6.3.5.2. Growth Prospects
  - 7.6.3.6. Others
    - 7.6.3.6.1. Market Opportunities and Trends
    - 7.6.3.6.2. Growth Prospects